Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Long-Term Debt, Maturity, Remainder of Fiscal Year

2.7 / 5 stars · 63/118 Roast Me

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Long-Term Debt, Maturity, Remainder of Fiscal Year

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $105.00 thousand as of 2021-09-25, per its 10-Q filed 2021-11-03.

Discontinued › Notes › Commitment and Contingencies

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2021-11-03

  • 2021-09-25: Long-Term Debt, Maturity, Remainder of Fiscal Year $105.00K.
  • 2021-06-26: Long-Term Debt, Maturity, Remainder of Fiscal Year $108.00K.
  • 2021-03-27: Long-Term Debt, Maturity, Remainder of Fiscal Year $109.00K.
Period endLong-Term Debt, Maturity, Remainder of Fiscal Year
2021-09-25$105.00K
10-Q · filed 2021-11-03
2021-06-26$108.00K
10-Q · filed 2021-08-04
2021-03-27$109.00K
10-Q · filed 2021-05-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71